NNNN — ANBIO BIOTECHNOLOGY
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
基本面(SEC EDGAR XBRL)
财务数据来自 SEC company facts,每项均按 EDGAR 提交日期做 point-in-time 对齐。
| 营收 TTM | 营收同比 | 净利 TTM | 净利同比 | ROE(TTM) | 毛利率 | 净利率 | 市盈率(TTM) | PE 分位 | 市净率 | PB 分位 |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
截至Q3 2026,共 16 家机构在其最新 13F 申报中持有 NNNN(ANBIO BIOTECHNOLOGY),合计申报市值 $1.01M,对应 160.89K 股。按股数计算较上季度减持 5.8%(-2.74K 股),申报市值环比下降 56.7%。持仓集中度较高:前五大持有人占申报市值的 75.9%,前十大的集中度为 99.7%。
与上一季度相比,8 家新建仓位、4 家加仓、4 家减仓、5 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。
ANBIO BIOTECHNOLOGY(NNNN)的主要机构持有人包括 GEODE CAPITAL MANAGEMENT, LLC、MILLENNIUM MANAGEMENT LLC、Millennium Management,按 13F 申报市值在本页 29 家持有人中排名居前。
NNNN 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 16 | 160.89K | $1.01M | -5.8% |
| Q2 2026 | 13 | 98.59K | $1.35M | -6.6% |
| Q1 2026 | 8 | 50.23K | $1.29M | +67.9% |
| Q4 2025 | 5 | 29.74K | $894.28K | -21.4% |
| Q3 2025 | 11 | 75.39K | $2.81M | +27.9% |
| Q2 2025 | 6 | 69.19K | $951.74K | +183.3% |
| Q1 2025 | 6 | 70.33K | $504.64K | -78.8% |
| Q4 2024 | 2 | 14.60K | $13.52K | -16.3% |
表内 8 个季度中,机构持股合计增加 1002%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2025(+183.3%)。
前 25 大机构持仓人(Q3 2026) — 16 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 26.71K | $168.26K | 0.00% | 新进 | |
| 26.71K | $168.26K | 0.00% | 新进 | |
| 25.61K | $161.33K | 0.00% | 新进 | |
| 22.21K | $139.92K | 0.00% | 减持 | |
| 20.93K | $131.00K | 0.00% | 新进 | |
| 19.11K | $120.41K | 0.00% | 增持 | |
| 16.51K | $103.99K | 0.00% | 新进 | |
| 1.80K | $11.34K | 0.00% | 减持 | |
| 634 | $3.99K | 0.00% | 减持 | |
| 188 | $1.16K | 0.00% | 增持 | |
| 144 | $907 | 0.00% | 新进 | |
| 108 | $680 | 0.00% | 增持 | |
| 97 | $611 | 0.00% | 新进 | |
| 96 | $605 | 0.00% | 增持 | |
| 31 | $195 | 0.00% | 减持 | |
| 10 | $63 | 0.00% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 13 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 26.74K | $366.55K | 0.00% | 新进 | |
| 26.74K | $366.55K | 0.00% | 增持 | |
| 13.42K | $183.97K | 0.00% | 新进 | |
| 11.80K | $161.78K | 0.00% | 增持 | |
| 11.50K | $157.69K | 0.00% | 新进 | |
| 7.23K | $99.14K | 0.00% | 减持 | |
| 828 | $11.35K | 0.00% | 减持 | |
| 187 | $2.56K | 0.00% | 减持 | |
| 77 | $1.06K | 0.00% | 新进 | |
| 53 | $718 | 0.00% | 新进 | |
| 15 | $206 | 0.00% | 持有 | |
| 5 | $69 | 0.00% | 新进 | |
| 4 | $55 | 0.00% | 新进 |
Q1 2026 — 8 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 25.76K | $661.85K | 0.00% | 持有 | |
| 10.40K | $267.18K | 0.00% | 增持 | |
| 7.34K | $188.51K | 0.00% | 增持 | |
| 6.34K | $162.85K | 0.00% | 增持 | |
| 266 | $6.83K | 0.00% | 新进 | |
| 100 | $2.57K | 0.00% | 持有 | |
| 15 | $385 | 0.00% | 新进 | |
| 5 | $128 | 0.00% | 新进 |
Q4 2025 — 5 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 25.76K | $774.69K | 0.00% | 持有 | |
| 2.85K | $85.67K | 0.00% | 增持 | |
| 1.00K | $30.07K | 0.00% | 减持 | |
| 100 | $3.01K | 0.00% | 持有 | |
| 28 | $842 | 0.00% | 减持 |
Q3 2025 — 11 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 25.76K | $959.67K | 0.00% | 增持 | |
| 10.44K | $389.00K | 0.00% | 新进 | |
| 8.61K | $320.72K | 0.00% | 增持 | |
| 7.08K | $263.73K | 0.00% | 新进 | |
| 7.08K | $263.73K | 0.00% | 新进 | |
| 6.90K | $256.88K | 0.01% | 新进 | |
| 6.01K | $223.00K | 0.00% | 新进 | |
| 2.42K | $90.11K | 0.00% | 增持 | |
| 960 | $35.76K | 0.00% | 减持 | |
| 100 | $3.73K | 0.00% | 持有 | |
| 21 | $782 | 0.00% | 新进 |
Q2 2025 — 6 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 17.13K | $542.34K | 0.00% | 持有 | |
| 10.70K | $338.60K | 0.00% | 增持 | |
| 1.26K | $39.92K | 0.00% | 新进 | |
| 39.60K | $15.05K | 0.00% | 增持 | |
| 400 | $12.66K | 0.00% | 新进 | |
| 100 | $3.17K | 0.00% | 新进 |
新建仓(Q3 2026)
- D. E. Shaw & Co., Inc. 26.71K 股 · $168.26K
- D. E. Shaw & Co 26.71K 股 · $168.26K
- STATE STREET CORP 25.61K 股 · $161.33K
- HRT FINANCIAL LP 20.93K 股 · $131.00K
- JANE STREET GROUP, LLC 16.51K 股 · $103.99K
- Superior Planning, LLC 144 股 · $907
- Ameritas Advisory Services, LLC 97 股 · $611
- Pinnacle Wealth Planning Services, Inc. 10 股 · $63
完全清仓(较上季)
- GEODE CAPITAL MANAGEMENT, LLC 卖出 26.74K 股 · $366.55K
- Bank of America Corp 卖出 13.42K 股 · $183.97K
- Marshall Wace 卖出 11.50K 股 · $157.69K
- Bare Financial Services, Inc 卖出 15 股 · $206
- Silver Grove Financial Group, Inc. 卖出 4 股 · $55
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 26.71K | — | — | — | — | — | — | — | — | — | — | — | — |
| D. E. Shaw & Co | 26.71K | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 25.61K | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 22.21K | 26.74K | 25.76K | 25.76K | 25.76K | 17.13K | 17.06K | — | — | — | — | — | — |
| HRT FINANCIAL LP | 20.93K | — | — | — | 6.01K | — | — | — | — | — | — | — | — |
| Morgan Stanley | 19.11K | 7.23K | 7.34K | 28 | 8.61K | 400 | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 16.51K | — | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 1.80K | 11.80K | 10.40K | 1.00K | 2.42K | 1.26K | — | — | — | — | — | — | — |
| UBS Group AG | 634 | 828 | 6.34K | 2.85K | 960 | 10.70K | 5.74K | — | — | — | — | — | — |
| JPMorgan Chase & Co | 188 | 53 | — | — | — | — | — | — | — | — | — | — | — |
| Superior Planning, LLC | 144 | — | — | — | — | — | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 108 | 77 | — | — | — | — | — | — | — | — | — | — | — |
| Ameritas Advisory Services, LLC | 97 | — | — | — | — | — | — | — | — | — | — | — | — |
| Larson Financial Group LLC | 96 | 5 | — | — | — | — | — | — | — | — | — | — | — |
| EverSource Wealth Advisors, LLC | 31 | 187 | 266 | — | — | — | — | — | — | — | — | — | — |
| Pinnacle Wealth Planning Services, Inc. | 10 | — | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | — | 11.50K | — | — | 10.44K | — | 43.63K | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 26.74K | — | — | — | — | — | — | — | — | — | — | — |
| MILLENNIUM MANAGEMENT LLC | — | — | — | — | 7.08K | — | — | — | — | — | — | — | — |
| XTX Topco Ltd | — | — | — | — | 6.90K | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold NNNN?
As of 2026-Q3, 16 institutional funds reported holding NNNN (ANBIO BIOTECHNOLOGY) in SEC 13F filings, with a combined reported value of $1.01M.
How many shares of NNNN do institutions own?
13F filers reported 160.89K shares of NNNN, worth $1.01M in aggregate at the end of 2026-Q3.
Is institutional ownership of NNNN rising or falling?
Share counts moved -5.8% versus the prior quarter — distribution.
Who are the top institutional holders of NNNN?
The largest 13F holders are GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, Millennium Management, XTX Topco Ltd, Bank of America Corp; the top 25 are ranked at the top of this page.
Who are the major shareholders of ANBIO BIOTECHNOLOGY?
The major shareholders of ANBIO BIOTECHNOLOGY (NNNN) by reported 13F value are GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, Millennium Management, XTX Topco Ltd, Bank of America Corp, among 29 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.